BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220421
DTEND;VALUE=DATE:20220701
DTSTAMP:20260516T022139
CREATED:20220425T094247Z
LAST-MODIFIED:20220519T120013Z
UID:33903-1650499200-1656633599@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China Virtual Expo Connect
DESCRIPTION:This year CPhI & P-MEC China returns as a SMART event\, combining 2 months of online event with a 3-day in-person event to help you connect for an extended period. \n \n“Virtual Expo Connect”\, to be held from 21st April – 30th June 2022\, is the digital extension of the physical CPhI & P-MEC China event that offers an online alternative for global pharma professionals. \nPowered by PharmaSources.com\, Virtual Expo Connect builds the online platform adding valued services and infinite opportunities to connect\, learn\, trade and grow. \nTo know more visit: https://www.pharmasources.com/vec2022
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-virtual-expo-connect-2/
LOCATION:Online
ORGANIZER;CN="Informa Markets":MAILTO:Yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220613
DTEND;VALUE=DATE:20220615
DTSTAMP:20260516T022139
CREATED:20220303T102140Z
LAST-MODIFIED:20220303T102140Z
UID:33430-1655078400-1655251199@www.pharmajournalist.com
SUMMARY:Pre Filled Syringes West Coast
DESCRIPTION:SMi’s 6th Annual Conference\nPre-Filled Syringes West Coast\nJune 13 – 14\, 2022 | San Diego\, CA\, USA \nSESSING DEVICE DEVELOPMENT AND REGULATION FOR ADVANCED INNOVATION \nSMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference\, to be held in San Diego. As part of SMi’s leading series of drug delivery device conferences\, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry\, device developer and regulatory perspectives. \n \nThe last year has seen major advances in device design and development with patient usability\, ease of use and safety remaining at the forefront. This upcoming conference will assess the industry movement towards enabling self-administration through advanced device design\, innovations in connectivity to aid the user\, and the increasing importance of biologics and novel drug product considerations for device development. Furthermore\, regulatory bodies and leaders from big pharma will give an international update on the fast-evolving industry landscape. As one of our most sought-after events\, this conference is not to be missed. \nThis two-day agenda offers you peer-to-peer networking with Global Product Managers\, Senior PFS Engineers\, Device Testing Managers\, Heads of Late-Stage PFS Development and many more. \nBenefits of attending: \n\nDiscover the latest advances in innovative device design for user-centric drug delivery\nAssess evolving approaches to platforms for advanced combination product portfolios\nUncover the key considerations to ensure optimal lifecycle management for drug delivery devices\nExplore how the industry is evolving with global developments including case studies of sustainable practices for drug delivery devices and the industry’s role in mass vaccination campaigns\nEngage in interactive sessions reviewing the landscape of on-body injectors for large volume delivery and the role of connectivity for wearable devices\n\nChAiRs foR 2022: \nTina Rees\, Associate Director\, Human Factors\, Regeneron Pharmaceuticals \nNatalie Abts\, Head of Human Factors Engineering\, Genentech \nFeatured 2022 speakers include:  \n\nSriman Banerjee\, Head of Packaging Development & Commercial Device Engineering\, Takeda\nAmin Sedighiamiri\, Associate Director\, Device Development\, AstraZeneca\nJames Wabby\, Executive Director\, Head of Regulatory Strategy\, Emerging Technologies and Combination Products\, Abbvie\nKhaudeja Bano\, Executive Medical Director\, Combination Product Safety Head\, Amgen\nRachel poker\, Associate Director\, Human Factors\, AstraZeneca\nKristina Li\, Sr. Engineer II\, Technical Development\, Biogen\nsujani Nannapaneni\, Human Factors Principal Research Engineer\, Combination Product Development\, Abbvie\n\nWho should attend? \n\nDrug-delivery developers\nMedical Device Engineers\nPrimary Packaging material designers\nSecondary packagers\nSmart device developers\nTraining device developers\nDevice-safety solution providers\nDrug developers\n\nPrevious attendees include: \nAbbott Laboratories; AbbVie; Advanced Molding Technologies; Aegerion Pharmaceuticals; Ajinomoto Althea\, Inc.; Allergan; Allergen Inc; Almac Group; Amgen; Antares Pharma; Aptar Pharma; AstraZeneca; Baxter Healthcare; BCM Group LLC; BioMarin; Boehringer Ingelheim; Connecticut Spring & Stamping; Credence MedSystems\, Inc.; Execution Metrics\, Inc; Ferring Pharmaceuticals; Fresenius-Kabi; Genentech; Genentech\, Inc.; Gilead Sciences; Glenmark Pharmaceuticals; Harro Hofliger Verpackungsmaschinen GmbH; Inovio Pharmaceuticals; iO Lifesciences; Ionis Pharmaceuticals; Ionis Pharmaceuticals\, Inc.; Matchstick; MedImmune; MedImmune LLC; Medizap; Medtronic; Merck & Co.; Mitsubishi Gas Chemical Company\, Inc; Nemera; Nipro PharmaPackaging; NOVO Engineering\, Inc.; Novo Nordisk; Novo Nordisk A/S; One World DMG; Owen Mumford; Pfenex; Pfenex Inc; Pfizer CentreOne; RAUMEDIC INC; Regeneron; Regeneron Pharmaceuticals; Regeneron Pharmaceuticals\, Inc.; Shire; Smithers Rapra; Steri-Tek; Stevanato Group S.p.A; Subcuject ApS; Suttons Creek Inc; Terumo Corporation; Terumo Medical Corporation; Terumo Pharmaceutical Solutions; UserWise\, Inc.; W. L. Gore & Associates\, Inc.; West Pharmaceutical Services; West Pharmaceutical Services\,; West Pharmaceuticals Services Inc; Worrell; Xeris Pharmaceuticals; ZebraSCI; zebrasci inc; ZEON CORPORATION; Zeon Specialty Materials ; Zeon Specialty Materials Inc \nFind out more here: http://www.prefilled-syringes-westcoast.com/ \nSMi Group offer direct access to key decision makers through tailored sponsorship\, exhibitor and delegate packages. For details contact Daniele Moreschi on +44 7498539226  \nAdditional Contact Info:\nT: +44 (0)20 7827 6088\nE: rjones@smi-online.co.uk\nFollow us: @SMiPharm #SMiPFSUSA
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-west-coast-2022/
LOCATION:San Diego\, CA\, USA
ORGANIZER;CN="SMi Events":MAILTO:rjones@smi-online.co.uk
END:VEVENT
END:VCALENDAR